[ibogaine] C.R.A.C.K

HSLotsof at aol.com HSLotsof at aol.com
Sun Jul 21 14:02:01 EDT 2002


In a message dated 7/21/02 1:38:23 PM, ptpeet at nyc.rr.com writes:

>Hey Howard,
>Is this up online somewhere, with a link, so I can link to it at Drugwar.com?
>Thanks.
>peace,
>Preston

Preston,

The letter originated with http://www.advocatesforpregnantwomen.org/  but, I 
didn't see it on their web page.  I just felt that Barbara Harris and 
C.R.A.C.K were getting into dangerous areas.

Howard
*********
 ----- Original Message ----- 

  From: HSLotsof at aol.com 

  To: ibogaine at mindvox.com 

  Sent: Saturday, July 20, 2002 10:54 PM

  Subject: [ibogaine] C.R.A.C.K



  Barbara Harris 

  Children Requiring A Caring Kommunity's 

  "Project Prevention" 

  P.O. Box 74 

  Stanton, CA 90680 


  Dear Ms. Harris: 


  We are writing to express our strong objections to your distribution of 

  highly misleading and completely inaccurate information regarding pregnant 

  women and methadone treatment. In a letter date February 22, 2002, you 
state, 

  in part: 


  "We are currently working with several methadone clinics that make our 
offer 

  known, and available, to the women and men who come through their program. 

  I'm sure one thing most can agree on is that it is important for those 
using 

  methadone or other drugs to refrain from getting pregnant." 


  We most certainly do not agree. Your statement, suggesting that it is 

  dangerous for a woman who is receiving clinically prescribed methadone 

  treatment to become pregnant, is simply wrong. Methadone is a highly 

  effective treatment for all opiate dependent patients and, most 
specifically, 

  for women - both before and after they may become pregnant. In fact, 
methadone

   treatment during pregnancy has not been associated with congenital 

  abnormalities or fetal demise. In those cases where neonatal withdrawal 

  symptoms occur (and they frequently do not), these symptoms can be treated 

  readily, with no evidence of any adverse impact on physical or cognitive 

  development. In short, there is simply no medical basis for your suggestion 

  that methadone patients should "refrain from getting pregnant." 


  For over 30 years, in countries throughout the world, methadone maintenance 

  treatment (MMT) has been shown to substantially reduce illegal opiate use 
and 

  the crime, illness, suffering, and death with which it is associated. The 

  benefits have been shown to accrue, not only to the individual patient, but 

  to his/her family and the community, as well. The most credible and 
objective 

  governmental and non-governmental organizations in America and abroad have 

  recognized these positive results with MMT. For example, the US Department 
of 

  Health and Human Services joins the scientific community in recognizing 
that 

  MMT greatly benefits the patients as well as the general community. It is 

  specifically recommended for pregnant and breast-feeding patients, which 

  further demonstrates the strong medical consensus supporting methadone 

  treatment, both in general and during pregnancy. 


  Unfortunately, despite methadone treatment's many benefits, it is available 

  to fewer than 20% of the people who most need it. Women, in particular, 
face 

  numerous barriers to obtaining this important medical intervention. Your 

  letter and activities, which spread false information and stigmatize 
current 

  and future mothers who receive this treatment, will make it even more 

  difficult for women who need methadone treatment to receive it. 


  We therefore urge you to withdraw this letter immediately and to advise 
each 

  of those individuals and clinics who received it that it was based on 

  misinformation. Furthermore, it is essential that you publicly repudiate 
the 

  inaccurate message you conveyed on your organization's website and in other 

  public and media context. Not to do so would be irresponsible and a great 

  disservice to those whose interests you claim to have at heart. 


  Signed, 



  Signatories 


  1. Lynn Singer, Ph.D, Professor of Pediatrics and Psychiatry, Case Western 

  Reserve University, School of Medicine 

  2. Stephen Kandall, MD, Retired Professor of Pediatrics, Albert Einstein 

  College of Medicine 

  3. Daniel Neuspiel, MD, MPH, Associate Chairman of Pediatrics, Beth Israel 

  Medical Center 

  4. Robert Newman, MD, Director, Baron Edmond de Rothschild Chemical 

  Dependency Institute of Beth Israel Medical Center 

  5. Barry Lester, Ph.D., Director, Infant Development Center, Women and 

  Infants’ Hospital 

  6. Mary Faith Marshall, Ph.D., Professor of Medicine and Bioethics, Kansas 

  University Medical Center 

  7. Maryann Amodeo, Ph.D., Professor, Boston University School of Social 
Work, 

  Alcohol and Drug Institute for Policy, Research and Training 

  8. Denise Paone, Ph.D., Evaluation and Training Consultant, Former 
Assistant 

  Director of Research, Chemical Dependency Institute, Beth Israel Medical 

  Center 

  9. John J. Botti, MD, Director, Maternal Fetal Medicine, Penn State Hershey 

  Medical Center 

  10. Mary Mahowald, Ph.D., Professor, Dept. of OB/GYN, University of Chicago 

  11. Machelle Allen, MD, Assistant Professor, Department of OB/GYN, NYU 
School 

  of Medicine 

  12. Wendy Chavkin, MD, MPH, Clinical Professor of Public Health and OB/GYN, 

  Columbia University, Mailman School of Public Health 

  13. Marjorie Greenfield MD, Associate Professor of OB/GYN, University 

  Hospitals of Cleveland, Case Western Reserve University School of Medicine 

  14. Hytham Imseis, MD, Mountain Area Health Education Center, Dept. of 
OB/GYN 

  15. Dona Upson, MD, Associate Professor of Medicine, University of New 
Mexico 

  16. Mack Lipkin, Jr., MD, Director of Primary Care, NYU School of Medicine 

  17. Ernest Drucker, Ph.D., Professor of Epidemiology and Social Medicine, 

  Montefiore Medical Center/Albert Einstein School of Medicine 

  18. Angela R. Holder, LLM, Professor of the Practice of Medical Ethics, 

  Center for the Study of Medical Ethics and Humanities, Duke University 

  Medical Center 

  19. Sydney L. Hans, Ph.D., Research Associate Professor, Department of 

  Psychiatry, University of Chicago 

  20. Craig Reinarman, Ph.D., Chair and Professor, Dept. of Sociology, UC 
Santa 

  Cruz 

  21. Rachel Roth, Ph.D., Assistant Professor, Washington University 

  22. Monica J. Casper, Ph.D., Associate Professor of Sociology, UC Santa 
Cruz 

  23. Anthony R. Kovner, Ph.D., Professor of Health Policy and Management, 

  Wagner/NYU 

  24. Susan L. Adams, Ph.D., RN, Associate Professor of Nursing, 
Women’s 

  Health Nurse Practitioner, Perinatal Addiction, Dominican University of 

  California 

  25. Nina Peskoe Peyser, Former Executive Director of the Chemical 
Dependency 

  Institute at Beth Israel Medical Center 

  26. Holly Catania, Baron Edmond de Rothschild Chemical Dependency Institute 

  of Beth Israel Medical Center 

  27. Nancy D. Campbell, Ph.D., Assistant Professor, Rensselaer Polytechnic 

  Institute 

  28. Jerome Richardson, Assistant Professor, University of Illinois at 
Chicago 

  29. Karyn L. Pomerantz, MLS, MPH, GW School of Public Health & Health 

  Services 

  30. Janet Lynne Golden, Ph.D., Associate Professor, Rutgers University 

  31. Cynthia Daniels, Ph.D., Associate Professor, Rutgers University 

  32. Drew Humphries, Ph.D., Department of Sociology, Anthropology and 
Criminal 

  Justice, 

  Rutgers University 

  33. Elizabeth M. Armstong, Ph.D., Assistant Professor, Princeton University 

  34. Jael Silliman, Ed.D., Associate Professor, University of Iowa 

  35. Jeanne Flavin, Ph.D., Associate Professor, Fordham University 

  36. Victor J. Bernstein, Ph.D., Associate Professor, University of Chicago 

  37. Grace Chang, Ph.D., Evergreen State College 

  38. Mario A. Caro, Ph.D. Candidate, Professor, Evergreen State College 

  39. Phillip Coffin, MIA, Project Director, Center for Urban Epidemiologic 

  Studies, New York Academy of Medicine 

  40. Sheigla Murphy, Ph.D., Institute for Scientific Analysis 

  41. Leslie D. McCrory, Clinical Supervisor, Health Partners 

  42. Ann D. Brown, CNM, MSN, Dept. of OB/GYN, Mountain Area Health Education 

  Center 

  43. Shelley Galvin, MA, Research & Grants Coordinator, Dept. of OB/GYN, 

  Mountain Area Health Education Center 

  44. Susan Shinn, RNC, Women’s Health, Mountain Area Health Education 

  Center 

  45. Melissa McClure, Medical Records Coordinator, Mountain Area Perinatal 

  Substance Abuse Program 

  46. Cheryl Timbs, Clinical Supervisor, Mountain Area Perinatal Substance 

  Abuse Program 

  47. Elizabeth Finger, LWW, Director of Behavior Medicine, Mountain Area 

  Health Education Center 

  48. Terry Sutton, Program Assistant, Mountain Area Health Education Center 

  49. Jean Cassidy, Dept. of OB/GYN, Mountain Area Health Education Center 

  50. Steve Allison, Certified Clinical Addiction Specialist, Mountain Area 

  Health Education Center 

  51. Gregory McCoy, Mountain Area Perinatal Substance Abuse Program 

  52. Michael Eisenberg, MD, MPH, President, ASPIRE 

  53. Luciano Colonna, Executive Director, Harm Reduction Project 

  54. Michael R. Aldrich, Ph.D 

  55. Ivan Zimmerman, J.D. 

  56. Rickie Solinger, Ph.D., Historian 

  57. National Women's Health Network 

  58. National Black Women’s Health Project 

  59. National Association for Public Health Policy Council on Illicit Drugs 

  60. Institute for Health and Recovery 

  61. Advocates for Recovery through Medicine (ARM) 

  62. Advocates for Recovery through Medicine (ARM) of Arkansas & Oklahoma 

  63. Advocates for Recovery through Medicine (ARM) of DC 

  64. Connecticut Women’s Consortium 

  65. Casa Segura 

  66. Lower East Side Harm Reduction Center 

  67. Addiction Treatment Watchdog 

  68. CAP Quality Care Methadone Clinic 

  69. Virginia Alliance of Methadone Advocates 

  70. Vermont Harm Reduction Coalition 

  71. San Francisco AIDS Foundation HIV Prevention Project 

  72. AIDS Project New Haven 

  73. HIV Law Project 

  74. ASPIRE 

  75. Drug Policy Alliance 

  76. Urban Justice Center 

  77. Criminal Justice Policy Institute 

  78. Center for Human Rights Education 

  79. Family Watch 

  80. Committee on Women, Population, and the Environment 

  81. Cambridge Cares About AIDS 

  82. California Coalition for Women Prisoners 

  83. Legal Services for Prisoners With Children 

  84. NORML Foundation 

  85. Common Sense for Drug Policy 

  86. Drug Policy Forum of Hawaii 

  87. ReconsiDer 

  88. Communities Against Rape and Abuse 

  89. Mikki Norris, Human Rights and the Drug War 

  90. Alice Diorio, President, Vermont Harm Reduction Coalition 

  91. Kevin Zeese, Executive Director, Common Sense for Drug Policy 

  92. Donna M. Shea, Legal Director, NORML 

  93. Mark Beresky, Secretary/Treasurer, Vermont Harm Reduction Coalition 

  94. Marc Shinderman, MD, CAP Quality Care Methadone Clinic 

  95. Cassie Pierson, Staff Attorney, Legal Services for Prisoners with 

  Children 

  96. Monique Tula, Director of Harm Reduction Services, Cambridge Cares 
About 

  AIDS 

  97. Eliza Wheeler, Needle Exchange Program Coordinator, Cambridge Cares 
About 

  AIDS 

  98. Robin Clark-Smith, AIDS Program, Bridgeport Health Department 

  99. Terri Bogage, Institute for Health and Recovery 

  100. Syd Lindsley, Committee on Women, Population, and the Environment 

  101. Jacqueline Robarge, Power Inside 

  102. Stephanie Manfre, Children’s Case Manager, Riley Center 

  103. Ann Beck, Riley Center 

  104. Jennifer Grant, Director, Riley Center 

  105. Teresa Martyny, Riley Center 

  106. Kylie Chow, Brennan House 

  107. JoAnn Yang, Riley Center 

  108. Michelle Rivera, Riley Center 

  109. Carolina Alaniz, Riley Center 

  110. Idoia Irastorza, Riley Center 

  111. Megan Koroshetz, Riley Center 

  112. Stacy Benedict, Riley Center 

  113. Liliana Diaz, San Francisco Department of Public Health 

  114. Ellenie Tuazon, San Francisco Department of Public Health 

  115. Elba Warner, San Francisco Department of Public Health 

  116. Ebone Colbert, Communities Against Rape and Abuse 

  117. Theryn Kigvamasud’Vashti, Communities Against Rape and Abuse 

  118. Alisa Bierria, Program Coordinator, Communities Against Rape and Abuse 

  119. Shane Felles 

  120. Brion Roberts 

  121. Susan Yanow, Director, Abortion Access Project 

  122. Shiela VanDerveer, Development Director, NARAL – NH 

  123. NOW Legal Defense and Education Fund 

  124. Marsha Rosenbaum, Ph.D., Director, Safety First Project, Drug Policy 

  Alliance 

  125. Ann M. Boyer, MD, MS, Mt. Sinai Medical Center 

  126. Nancy Mamis-King, Associate Executive Director, Neighborhood Youth & 

  Family Services 

  127. Maureen Denman, Atlantic Health System 

  128. Shelly Carter, Health Educator, New Mexico Prenatal Care Network, 

  University of New Mexico 

  129. National Council on Alcoholism & Drug Dependence 

  130. Gloria Knighton 

  131. Virginia Nurses Society on Addictions 

  132. National Alliance of Methadone Advocates 

  133. National Advocates for Pregnant Women

 




More information about the Ibogaine mailing list